These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Repeatability of amide proton transfer-weighted signals in the brain according to clinical condition and anatomical location. Lee JB; Park JE; Jung SC; Jo Y; Kim D; Kim HS; Choi CG; Kim SJ; Kang DW Eur Radiol; 2020 Jan; 30(1):346-356. PubMed ID: 31338651 [TBL] [Abstract][Full Text] [Related]
3. Amide proton transfer-weighted imaging and derived radiomics in the classification of adult-type diffuse gliomas. Wu M; Jiang T; Guo M; Duan Y; Zhuo Z; Weng J; Xie C; Sun J; Li J; Cheng D; Liu X; Du J; Zhang X; Zhang Y; Liu Y Eur Radiol; 2024 May; 34(5):2986-2996. PubMed ID: 37855851 [TBL] [Abstract][Full Text] [Related]
9. Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla. Jiang S; Yu H; Wang X; Lu S; Li Y; Feng L; Zhang Y; Heo HY; Lee DH; Zhou J; Wen Z Eur Radiol; 2016 Jan; 26(1):64-71. PubMed ID: 25925361 [TBL] [Abstract][Full Text] [Related]
10. Predicting O6-Methylguanine-DNA Methyltransferase Protein Expression in Primary Low- and High-Grade Gliomas Using Certain Qualitative Characteristics of Amide Proton Transfer-Weighted Magnetic Resonance Imaging. Su L; Gao P; Lin S; Wu B; Qin W; Lin Y; Xue J World Neurosurg; 2018 Aug; 116():e814-e823. PubMed ID: 29803064 [TBL] [Abstract][Full Text] [Related]
11. Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomas. Durmo F; Rydhög A; Testud F; Lätt J; Schmitt B; Rydelius A; Englund E; Bengzon J; van Zijl P; Knutsson L; Sundgren PC PLoS One; 2020; 15(12):e0244003. PubMed ID: 33373375 [TBL] [Abstract][Full Text] [Related]
12. Amide proton transfer-weighted MRI in the clinical setting - correlation with dynamic susceptibility contrast perfusion in the post-treatment imaging of adult glioma patients at 3T. Friismose AI; Markovic L; Nguyen N; Gerke O; Schulz MK; Mussmann BR Radiography (Lond); 2022 Feb; 28(1):95-101. PubMed ID: 34509365 [TBL] [Abstract][Full Text] [Related]
13. Comparison of amide proton transfer imaging and magnetization transfer imaging in revealing glioma grades and proliferative activities: a histogram analysis. Su C; Jiang J; Liu C; Shi J; Li S; Chen X; Ao Q Neuroradiology; 2021 May; 63(5):685-693. PubMed ID: 32997164 [TBL] [Abstract][Full Text] [Related]
14. Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas. Schön S; Cabello J; Liesche-Starnecker F; Molina-Romero M; Eichinger P; Metz M; Karimov I; Preibisch C; Keupp J; Hock A; Meyer B; Weber W; Zimmer C; Pyka T; Yakushev I; Gempt J; Wiestler B Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1468-1475. PubMed ID: 31953672 [TBL] [Abstract][Full Text] [Related]
15. Amide proton transfer-weighted imaging of the head and neck at 3 T: a feasibility study on healthy human subjects and patients with head and neck cancer. Yuan J; Chen S; King AD; Zhou J; Bhatia KS; Zhang Q; Yeung DK; Wei J; Mok GS; Wang YX NMR Biomed; 2014 Oct; 27(10):1239-47. PubMed ID: 25137521 [TBL] [Abstract][Full Text] [Related]
16. Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI. Jiang S; Zou T; Eberhart CG; Villalobos MAV; Heo HY; Zhang Y; Wang Y; Wang X; Yu H; Du Y; van Zijl PCM; Wen Z; Zhou J Magn Reson Med; 2017 Sep; 78(3):1100-1109. PubMed ID: 28714279 [TBL] [Abstract][Full Text] [Related]
17. Amide proton transfer (APT) and magnetization transfer (MT) in predicting short-term therapeutic outcome in nasopharyngeal carcinoma after chemoradiotherapy: a feasibility study of three-dimensional chemical exchange saturation transfer (CEST) MRI. Liu W; Wang X; Xie S; Liu WV; Masokano IB; Bai Y; Chen J; Zhong L; Luo Y; Zhou G; Li W; Pei Y Cancer Imaging; 2023 Sep; 23(1):80. PubMed ID: 37658446 [TBL] [Abstract][Full Text] [Related]
18. Amide proton transfer imaging of glioblastoma, neuroblastoma, and breast cancer cells on a 11.7 T magnetic resonance imaging system. Tanoue M; Saito S; Takahashi Y; Araki R; Hashido T; Kioka H; Sakata Y; Yoshioka Y Magn Reson Imaging; 2019 Oct; 62():181-190. PubMed ID: 31302222 [TBL] [Abstract][Full Text] [Related]
19. Generalization of quasi-steady-state reconstruction to CEST MRI with two-tiered RF saturation and gradient-echo readout-Synergistic nuclear Overhauser enhancement contribution to brain tumor amide proton transfer-weighted MRI. Sun PZ Magn Reson Med; 2023 May; 89(5):2014-2023. PubMed ID: 36579767 [TBL] [Abstract][Full Text] [Related]
20. Amide proton transfer-weighted MRI in distinguishing high- and low-grade gliomas: a systematic review and meta-analysis. Suh CH; Park JE; Jung SC; Choi CG; Kim SJ; Kim HS Neuroradiology; 2019 May; 61(5):525-534. PubMed ID: 30666352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]